Emcure Pharmaceuticals (NSE:EMCURE) EBIT per Share : ₹56.92 (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals EBIT per Share?

Emcure Pharmaceuticals's EBIT per Share for the six months ended in Sep. 2024 was ₹31.71. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹56.92.

During the past 12 months, the average EBIT per Share Growth Rate of Emcure Pharmaceuticals was -2.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Emcure Pharmaceuticals's EBIT per Share or its related term are showing as below:

NSE:EMCURE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -0.4 Med: -0.4 Max: -0.4
Current: -0.4

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Emcure Pharmaceuticals was -0.40% per year. The lowest was -0.40% per year. And the median was -0.40% per year.

NSE:EMCURE's 3-Year EBIT Growth Rate is ranked worse than
62.41% of 830 companies
in the Drug Manufacturers industry
Industry Median: 6.6 vs NSE:EMCURE: -0.40

Emcure Pharmaceuticals's EBIT for the six months ended in Sep. 2024 was ₹5,858 Mil.

Emcure Pharmaceuticals EBIT per Share Historical Data

The historical data trend for Emcure Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals EBIT per Share Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

EBIT per Share

55.07

62.72

51.93

52.90

Emcure Pharmaceuticals Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EBIT per Share	Get a 7-Day Free Trial			21.35	30.58	27.68	25.21	31.71

Emcure Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Emcure Pharmaceuticals's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	9560.02	/	180.719
=	52.90

Emcure Pharmaceuticals's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	5857.98	/	184.753
=	31.71

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹56.92

Emcure Pharmaceuticals (NSE:EMCURE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Emcure Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » EBIT per Share

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines